Artha Sootra - Company Dashboard

Governance Classic Home

Senores Pharmaceuticals LtdPharmaceuticalsINE0RB801010Consolidated₹1136.35-7.50 (-0.66%)

Valuation

Market Cap₹5.24K Cr

TTM PE37.02x

Forward PE36.41x

PEG4.55

Book Value₹217.79

P/B5.22x

TTM EPS₹30.71

Fwd EPS₹31.23

TTM Revenue₹722.29 Cr

TTM PAT₹137.30 Cr

TTM EBITDA₹212.91 Cr

TTM EBIT₹175.57 Cr

Last Qtr PAT₹36.60 Cr

Last Qtr EBITDA₹57.66 Cr

Last Qtr EBIT₹47.41 Cr

Profitability

ROE13.69%

ROCE14.78%

TTM NPM19.01%

TTM EBITDA %29.48%

Curr OPM18.18%

Last OPM16.64%

Curr NPM—

Last NPM—

Curr EPS₹8.85

Last EPS₹6.61

Balance sheet

Equity₹46.05 Cr

Reserve₹956.93 Cr

Total Debt₹409.43 Cr

D/E0.41x

Interest %23.96%

Curr Interest₹8.77 Cr

Price / range

Close₹1137.00

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D-0.87%

1W-14.18%

1M-15.76%

3M-16.52%

6M+27.30%

1Y+48.28%

2Y—

3Y—

5Y—

Diwali+37.54%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	35.65+0.9%	26.99	36.81	28.76	35.33	106.09
Other Income	14.76	9.55	22.19	9.78	11.36	66.35
Total Income	50.41+8.0%	36.54	59	38.54	46.69	172.44
Interest	2.22	2.22	1.89	1.75	1.58	6.98
Expenditure	-40.74-4.4%	-35.15	-46.31	-35.02	-39.04	-144.98
PBDT	0	0	0	0	0	0
EBITDA	1.06-30.3%	-2.33	-3.48	-0.93	1.52	-18.68
Depreciation	-3.93	-3.61	-4.13	-3.58	-3.65	-13.23
EBIT	-2.87-34.7%	-5.94	-7.61	-4.51	-2.13	-31.91
PBT	9.67+26.4%	1.39	12.69	3.52	7.65	27.46
Tax	-1.95	-0.36	-4.21	-0.87	-1.22	-7.21
Equity	46.05	46.05	46.05	0	0	46.05
OPM	19.18	3.80	21.51	12.24	21.65	15.92
Net Profit	7.72+20.1%	1.03	8.48	2.65	6.43	20.25
NPM	15.31	2.82	14.37	9.21	18.20	11.74
EPS	1.68+20.0%	0.22	1.84	1.98	1.40	4.40

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	106.09+175.3%	38.54
Other Income	66.35	21.99
Total Income	172.44+184.9%	60.53
Expenditure	-144.98-161.6%	-55.42
Interest	-6.98	-6.52
PBDT	0	0
EBITDA	-18.68-156.6%	-7.28
Depreciation	-13.23	-3.08
EBIT	-31.91-208.0%	-10.36
PBT	27.46+437.4%	5.11
Tax	-7.21	-1.42
Equity	46.05	46.05
OPM (%)	15.92	8.44
Net Profit	20.25+448.8%	3.69
NPM (%)	11.74	6.10
EPS (Rs)	4.40+331.4%	1.02
CEPS	4.40	1.02

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	192.33+18.9%	180.21	175.19	174.56	161.76	632.63
Other Income	8.94	2.81	17.67	3.78	5.41	47.06
Total Income	201.27+20.4%	183.02	192.86	178.34	167.17	679.69
Interest	8.77	7.17	8.46	5.33	6.19	25.03
Expenditure	-153.69-21.5%	-143.56	-145.46	-133.74	-126.53	-520.59
PBDT	0	0	0	0	0	0
EBITDA	57.66+16.5%	53.76	47.49	54	49.51	168.32
Depreciation	-10.25	-9.94	-9.30	-7.85	-8.09	-31.25
EBIT	47.41+14.5%	43.82	38.19	46.15	41.42	137.07
PBT	47.58+17.1%	39.46	47.40	44.60	40.64	159.10
Tax	-10.98	-9.01	-10.73	-11.02	-10.52	-37.57
Equity	46.05	46.05	46.05	0	46.05	46.05
OPM	23.64	21.56	24.58	25.01	24.31	23.41
Net Profit	36.60+21.5%	30.45	36.67	33.58	30.12	121.53
NPM	18.18	16.64	19.01	18.83	18.02	17.88
EPS	8.85+35.3%	6.61	7.96	7.29	6.54	26.39

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	632.63+58.9%	398.25
Other Income	47.06	19.26
Total Income	679.69+62.8%	417.51
Expenditure	-520.59-50.1%	-346.94
Interest	-25.03	-21.55
PBDT	0	0
EBITDA	168.32+87.6%	89.70
Depreciation	-31.25	-16.84
EBIT	137.07+88.1%	72.86
PBT	159.10+125.4%	70.57
Tax	-37.57	-12.23
Equity	46.05	46.05
OPM (%)	23.41	16.90
Net Profit	121.53+108.3%	58.34
NPM (%)	17.88	13.97
EPS (Rs)	26.39+63.7%	16.12
CEPS	26.39	16.12

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split